Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Synergy Biomedical, LLC (www.synergybiomedical.com) announced today that it has recently received FDA clearance and will be launching its first bone graft product, BioSphere™ Putty. Utilizing a specialized form of 45S5 bioactive glass with a unique sphere shape and a narrow size range, BioSphere™ Putty provides an optimized bone graft material that outperforms other bioactive products. The spherical shape of the BioSphere™ particles provides uniform and repeatable resorption and ion release. In addition, the 3-D packing of the spheres in a bone defect creates an optimal porosity that allows bone formation throughout the implant. Biosphere™ Putty is composed of bioactive glass spheres that are combined with a moldable phospholipid carrier. The Putty has the highest bioactive glass composition on the market, provides excellent handling, and is resistant to irrigation. This combination results in a high performance bone graft that provides faster and more robust bone formation.
Help employers find you! Check out all the jobs and post your resume.
